MicroRNA-301b-3p Downregulation Underlies a Novel Inhibitory Role of Long Non-coding RNA MBNL1-AS1 in Non-small Cell Lung Cancer

Overview

Journal Stem Cell Res Ther

Publisher Biomed Central

Date 2019 May 23

PMID 31113460

Citations 25

Authors

Peng Li

Wenqun Xing

Jinliang Xu

Dongfeng Yuan

Guanghui Liang

Baoxing Liu

Haibo Ma

Affiliations

Soon will be listed here.

Abstract

Background: Non-small cell lung cancer (NSCLC) is the second most prevalent cause of cancer-related fatality. Long non-coding RNAs (lncRNAs) have been observed to exercise functions in NSCLC. Here, the current study aimed to explore the potential mechanism of lncRNA MBNL1-AS1 in NSCLC.

Methods: Microarray analysis was performed to screen the differentially expressed lncRNA associated with NSCLC and its potential mechanism. The lncRNA MBNL1-AS1 expression was quantified in 56 paired NSCLC and adjacent normal tissue samples. In an attempt to outline the function of lncRNA MBNL1-AS1 in NSCLC and to identify the interaction among lncRNA MBNL1-AS1, microRNA-301b-3p (miR-301b-3p) and TGFBR2, ectopic expression, depletion, and reporter assay experiments were conducted to detect CSC proliferation, migration, invasion, drug resistance, and sphere formation in NSCLC.

Results: Initially, the intersection among lncRNA MBNL1-AS1, miR-301b-3p, and TGFBR2 was observed in NSCLC. While a poor expression of lncRNA MBNL1-AS1 and TGFBR2, along with a high expression of miR-301b-3p was observed in NSCLC tissues. A demonstration of lncRNA MBNL1-AS1 restoration significantly decreased CSC proliferation, migration, invasion, drug resistance, and sphere formation in NSCLC. LncRNA MBNL1-AS1 functioned as a sponge of miR-301b-3p, which inverted the inhibitory role of lncRNA MBNL1-AS1 in CSC proliferation, migration, invasion, drug resistance, and sphere formation in NSCLC. LncRNA MBNL1-AS1 positively regulated TGFBR2 which was a target gene of miR-301b-3p. At last, upregulated lncRNA MBNL1-AS1 or depleted miR-301b-3p suppressed the xenograft tumor formation in vivo.

Conclusion: Collectively, the present study suggests an inhibitory role of lncRNA MBNL1-AS1 in CSC drug resistance of NSCLC by upregulating miR-301b-3p-targeted TGFBR2.

Citing Articles

MicroRNAs: circulating biomarkers for the early detection of imperceptible cancers via biosensor and machine-learning advances.

Metcalf G Oncogene. 2024; 43(28):2135-2142.

PMID: 38839942 PMC: 11226400. DOI: 10.1038/s41388-024-03076-3.

Advances and Challenges in Cancer Stem Cells for Onco-Therapeutics.

Alnasser S Stem Cells Int. 2023; 2023:8722803.

PMID: 38094260 PMC: 10719005. DOI: 10.1155/2023/8722803.

Role of miR-301b-3p/5p in breast cancer: A study based on the cancer GenomeAtlas program (TCGA) and bioinformatics analysis.

Zhou Q, Wang F, Sun E, Liu X, Lu C Noncoding RNA Res. 2023; 8(4):571-578.

PMID: 37602319 PMC: 10432899. DOI: 10.1016/j.ncrna.2023.08.002.

LncRNA MBNL1-AS1 Suppresses Cell Proliferation and Metastasis of Pancreatic Adenocarcinoma through Targeting Carcinogenic miR-301b-3p.

Sulidankazha C, Alidake , Lin H, He T, Han W, Chen Q Genet Res (Camb). 2023; 2023:6785005.

PMID: 36908851 PMC: 9995204. DOI: 10.1155/2023/6785005.

Preparation, characterisation, and in vitro cancer-suppression function of RNA nanoparticles carrying miR-301b-3p Inhibitor.

Zhao J, Niu N, Yang F, Liu H, Qi W IET Nanobiotechnol. 2023; 17(3):224-233.

PMID: 36892102 PMC: 10190642. DOI: 10.1049/nbt2.12120.

References

Zhao C, Setrerrahmane S, Xu H . Enrichment and characterization of cancer stem cells from a human non-small cell lung cancer cell line. Oncol Rep. 2015; 34(4):2126-32. DOI: 10.3892/or.2015.4163. View

Cao S, Wang Z, Gao X, He W, Cai Y, Chen H . FOXC1 induces cancer stem cell-like properties through upregulation of beta-catenin in NSCLC. J Exp Clin Cancer Res. 2018; 37(1):220. PMC: 6127900. DOI: 10.1186/s13046-018-0894-0. View

Wang R, Dong H, Zeng J, Pan J, Jin X . LncRNA DGCR5 contributes to CSC-like properties via modulating miR-330-5p/CD44 in NSCLC. J Cell Physiol. 2018; 233(9):7447-7456. DOI: 10.1002/jcp.26590. View

Lv J, Fan H, Zhao X, Lv P, Fan J, Zhang Y . Long non-coding RNA Unigene56159 promotes epithelial-mesenchymal transition by acting as a ceRNA of miR-140-5p in hepatocellular carcinoma cells. Cancer Lett. 2016; 382(2):166-175. DOI: 10.1016/j.canlet.2016.08.029. View

Xue J, Xue J, Zhang J, Li D, Jiang L . miR-130b-3p/301b-3p negatively regulated Rb1cc1 expression on myogenic differentiation of chicken primary myoblasts. Biotechnol Lett. 2017; 39(11):1611-1619. DOI: 10.1007/s10529-017-2400-8. View

Zhang J, Wang J, Zhao F, Liu Q, Jiang K, Yang G . MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC). Clin Chim Acta. 2010; 411(11-12):846-52. DOI: 10.1016/j.cca.2010.02.074. View

Fu Y, Ramisetty S, Hussain N, Baranger A . MBNL1-RNA recognition: contributions of MBNL1 sequence and RNA conformation. Chembiochem. 2011; 13(1):112-9. PMC: 3890438. DOI: 10.1002/cbic.201100487. View

Fehrenbacher L, Spira A, Ballinger M, Kowanetz M, Vansteenkiste J, Mazieres J . Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial. Lancet. 2016; 387(10030):1837-46. DOI: 10.1016/S0140-6736(16)00587-0. View

Wu Z, Li Y, Zhang G . Downregulation of microRNA-301a inhibited proliferation, migration and invasion of non-small cell lung cancer by directly targeting DLC1. Oncol Lett. 2017; 14(5):6017-6023. PMC: 5661386. DOI: 10.3892/ol.2017.6990. View

10.

Nie F, Sun M, Yang J, Xie M, Xu T, Xia R . Long noncoding RNA ANRIL promotes non-small cell lung cancer cell proliferation and inhibits apoptosis by silencing KLF2 and P21 expression. Mol Cancer Ther. 2014; 14(1):268-77. DOI: 10.1158/1535-7163.MCT-14-0492. View

11.

Foss K, Sima C, Ugolini D, Neri M, Allen K, Weiss G . miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer. J Thorac Oncol. 2011; 6(3):482-8. DOI: 10.1097/JTO.0b013e318208c785. View

12.

Funamizu N, Lacy C, Parpart S, Takai A, Hiyoshi Y, Yanaga K . MicroRNA-301b promotes cell invasiveness through targeting TP63 in pancreatic carcinoma cells. Int J Oncol. 2014; 44(3):725-34. DOI: 10.3892/ijo.2014.2243. View

13.

Yu C, Hu F, Yu C, Chou M . Targeting CD133 in the enhancement of chemosensitivity in oral squamous cell carcinoma-derived side population cancer stem cells. Head Neck. 2014; 38 Suppl 1:E231-8. DOI: 10.1002/hed.23975. View

14.

Zakaria N, Abdul Satar N, Abu Halim N, Ngalim S, Mohd Yusoff N, Lin J . Targeting Lung Cancer Stem Cells: Research and Clinical Impacts. Front Oncol. 2017; 7:80. PMC: 5418222. DOI: 10.3389/fonc.2017.00080. View

15.

Tang R, Qi Q, Wu R, Zhou X, Wu D, Zhou H . The polymorphic terminal-loop of pre-miR-1307 binding with MBNL1 contributes to colorectal carcinogenesis via interference with Dicer1 recruitment. Carcinogenesis. 2015; 36(8):867-75. DOI: 10.1093/carcin/bgv066. View

16.

Xie X, Liu H, Mei J, Ding F, Xiao H, Hu F . LncRNA HMlincRNA717 is down-regulated in non-small cell lung cancer and associated with poor prognosis. Int J Clin Exp Pathol. 2015; 7(12):8881-6. PMC: 4314049. View

17.

Zhang H, Chen X, Wang M, Wang J, Qi Q, Zhang R . Defective expression of transforming growth factor beta receptor type II is associated with CpG methylated promoter in primary non-small cell lung cancer. Clin Cancer Res. 2004; 10(7):2359-67. DOI: 10.1158/1078-0432.ccr-0959-3. View

18.

Wang L, Ma L, Xu F, Zhai W, Dong S, Yin L . Role of long non-coding RNA in drug resistance in non-small cell lung cancer. Thorac Cancer. 2018; 9(7):761-768. PMC: 6026617. DOI: 10.1111/1759-7714.12652. View

19.

Fort R, Matho C, Oliveira-Rizzo C, Garat B, Sotelo-Silveira J, Duhagon M . An integrated view of the role of miR-130b/301b miRNA cluster in prostate cancer. Exp Hematol Oncol. 2018; 7:10. PMC: 5930504. DOI: 10.1186/s40164-018-0102-0. View

20.

Ceppi P, Mudduluru G, Kumarswamy R, Rapa I, Scagliotti G, Papotti M . Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in non-small cell lung cancer. Mol Cancer Res. 2010; 8(9):1207-16. DOI: 10.1158/1541-7786.MCR-10-0052. View